160 related articles for article (PubMed ID: 8946278)
1. Natural killing activity in patients with spontaneous regression of malignant lymphoma.
Ono K; Kikuchi M; Funai N; Matsuzaki M; Shimamoto Y
J Clin Immunol; 1996 Nov; 16(6):334-9. PubMed ID: 8946278
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of natural killing activity in patients with advanced lymphoma.
Ono K
J Clin Immunol; 1998 Mar; 18(2):132-41. PubMed ID: 9533657
[TBL] [Abstract][Full Text] [Related]
3. Natural killing activities in chronic liver diseases and hepatocellular carcinoma.
Ono K; Yamanaga Y; Yamamoto K; Koga SI; Nishimura J; Nawata H
J Clin Immunol; 1996 Jan; 16(1):41-5. PubMed ID: 8926284
[TBL] [Abstract][Full Text] [Related]
4. Depressed spontaneous natural killing and interferon augmentation in patients with malignant lymphoma.
Hawrylowicz CM; Rees RC; Hancock BW; Potter CW
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1081-8. PubMed ID: 6891651
[TBL] [Abstract][Full Text] [Related]
5. [T-cell lymphomas and "natural killer". Histopathologic, immunologic and molecular aspects].
Kanavaros P; Gaulard P
Ann Pathol; 1998 Oct; 18(4):299-314. PubMed ID: 9827221
[No Abstract] [Full Text] [Related]
6. Natural killer cell activity of peripheral blood and bone marrow mononuclear cells from patients with childhood acute lymphoblastic leukemia.
Sørskaar D; Lie SO; Førre O
Acta Paediatr Scand; 1985 May; 74(3):433-7. PubMed ID: 3859177
[TBL] [Abstract][Full Text] [Related]
7. A new analysis of natural killing activity and the role of monocytes in normal subjects.
Ono K; Shimamoto Y; Nishimura J; Yamaguchi M; Nawata H
J Clin Lab Immunol; 1989 Dec; 30(4):175-81. PubMed ID: 2534974
[TBL] [Abstract][Full Text] [Related]
8. Induction of malignant lymphoreticular cell line which displays spontaneous killer-cell activity.
Kerbel RS; Roder JC; Pross HF
Int J Cancer; 1981 Jan; 27(1):87-94. PubMed ID: 7251232
[TBL] [Abstract][Full Text] [Related]
9. Nasal natural killer/T-cell lymphoma: report of three cases.
Martínez-Casimiro L; Reboll R; Armengot M; Marín S; García-Melgares ML; Gaona JJ; Pérez-Ferriols A; Alegre V
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):447-8. PubMed ID: 18631203
[No Abstract] [Full Text] [Related]
10. Enhanced natural killer cell activity is found in exposed uninfected recipients of hepatitis C-contaminated blood.
Ow MM; Hegazy D; Warshow UM; Cramp ME
J Viral Hepat; 2018 Mar; 25(3):245-253. PubMed ID: 29063663
[TBL] [Abstract][Full Text] [Related]
11. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
12. Measurement of NK activity by the microcytotoxicity assay (MCA): a new application for an old assay.
Wahlberg BJ; Burholt DR; Kornblith P; Richards TJ; Bruffsky A; Herberman RB; Vujanovic NL
J Immunol Methods; 2001 Jul; 253(1-2):69-81. PubMed ID: 11384670
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype.
Boehrer S; Schui DK; Chow KU; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2002 Dec; 43(12):2363-8. PubMed ID: 12613525
[TBL] [Abstract][Full Text] [Related]
14. Metastasis of mouse T lymphoma cells is controlled by the level of major histocompatibility complex class I H-2Dk antigens.
VandenDriessche T; Geldhof A; Bakkus M; Toussaint-Demylle D; Brijs L; Thielemans K; Verschueren H; De Baetselier P
Int J Cancer; 1994 Jul; 58(2):217-25. PubMed ID: 8026885
[TBL] [Abstract][Full Text] [Related]
15. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course.
Mraz-Gernhard S; Natkunam Y; Hoppe RT; LeBoit P; Kohler S; Kim YH
J Clin Oncol; 2001 Apr; 19(8):2179-88. PubMed ID: 11304770
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
[TBL] [Abstract][Full Text] [Related]
17. Influence of elevated temperature on natural killer cell activity, lymphokine-activated killer cell activity and lectin-dependent cytotoxicity of human umbilical cord blood and adult blood cells.
Shen RN; Lu L; Young P; Shidnia H; Hornback NB; Broxmeyer HE
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):821-6. PubMed ID: 8040029
[TBL] [Abstract][Full Text] [Related]
18. Agonistic effects of anti-CD2 and anti-CD16 antibodies on human natural killer killing.
Uggla CK; Geisberg M; Jondal M; Knowles RW
Scand J Immunol; 1989 May; 29(5):507-15. PubMed ID: 2567053
[TBL] [Abstract][Full Text] [Related]
19. Modulation of natural killer cell function leading to spontaneous regression of a histiocytoma.
Bright JJ; Hegde SP; Begum Z; Khar A
Cell Immunol; 1994 Mar; 154(1):54-65. PubMed ID: 8118890
[TBL] [Abstract][Full Text] [Related]
20. Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity.
Geldhof AB; Raes G; Bakkus M; Devos S; Thielemans K; De Baetselier P
Cancer Res; 1995 Jul; 55(13):2730-3. PubMed ID: 7540948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
